These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8873385)

  • 1. Economic aspects of vaccination.
    Demicheli V; Jefferson T
    Vaccine; 1996 Jul; 14(10):941-3. PubMed ID: 8873385
    [No Abstract]   [Full Text] [Related]  

  • 2. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 impact on infant and adolescent vaccine supplies.
    Cernuschi T; Malvolti S; Downham M; Maugeais D; Robinson D; Cravioto A
    Science; 2021 Dec; 374(6574):1438-1441. PubMed ID: 34914520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination: cost-effectiveness ratio].
    Swennen B
    Rev Med Brux; 2009 Sep; 30(4):451-7. PubMed ID: 19899394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical network for logistics in health (Technet).
    Wkly Epidemiol Rec; 1999 Apr; 74(17):129-35. PubMed ID: 10382370
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012.
    Cortés I; Pérez-Camarero S; Del Llano J; Peña LM; Hidalgo-Vega A
    Vaccine; 2013 Aug; 31(35):3473-84. PubMed ID: 23764534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination in food animal populations.
    van Oirschot JT
    Vaccine; 1994 Apr; 12(5):415-8. PubMed ID: 8023549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases' burden.
    Šmit R; Postma MJ
    Expert Rev Vaccines; 2016; 15(1):5-7. PubMed ID: 26559456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How and why researchers use the number needed to vaccinate to inform decision making--a systematic review.
    Hashim A; Dang V; Bolotin S; Crowcroft NS
    Vaccine; 2015 Feb; 33(6):753-8. PubMed ID: 25543164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [National economic consequences of vaccines].
    Bergman A; Persson U
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1680-4. PubMed ID: 18590011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Child vaccines--new possibilities. The Danish Society of Pediatrics].
    Falck L; Andersen V; Høgh B;
    Ugeskr Laeger; 2007 Mar; 169(12):1128. PubMed ID: 17394839
    [No Abstract]   [Full Text] [Related]  

  • 12. [News about zoonoses. International cooperation is necessary for development of vaccines, vector control and education].
    Settergren B; Granström M
    Lakartidningen; 1997 Jun; 94(23):2171-2. PubMed ID: 9213680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Do we know what we do when vaccinating? Positive and negative effects observed. Unspecific immunostimulating mechanisms are still to be explained].
    Aaby P
    Lakartidningen; 2004 Jan; 101(4):294-7. PubMed ID: 14979004
    [No Abstract]   [Full Text] [Related]  

  • 14. [New vaccines. What can we expect in the coming years?].
    Bjune G; Nøkleby HM
    Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3032-4. PubMed ID: 7570534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative.
    Andrus JK; Toscano CM; Lewis M; Oliveira L; Ropero AM; Dávila M; Fitzsimmons JW
    Public Health Rep; 2007; 122(6):811-6. PubMed ID: 18051674
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost-effectiveness of vaccinating against Lyme disease.
    Prybylski D
    Emerg Infect Dis; 1999; 5(5):727-8. PubMed ID: 10511535
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of pneumococcal vaccine.
    Le C
    JAMA; 2000 Jul; 284(4):440; author reply 440-1. PubMed ID: 10904499
    [No Abstract]   [Full Text] [Related]  

  • 18. 3rd Global Vaccine Congress.
    Kyd JM
    Expert Rev Vaccines; 2010 Jan; 9(1):13-7. PubMed ID: 20021300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of pneumococcal vaccine.
    Meyerhoff AS; Jacobs RJ
    JAMA; 2000 Jul; 284(4):440-1. PubMed ID: 10904500
    [No Abstract]   [Full Text] [Related]  

  • 20. Eighth World Congress on Vaccines, Immunisation and Immunotherapy.
    Kurstak E
    Hum Vaccin Immunother; 2013 Mar; 9(3):449. PubMed ID: 23454870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.